Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04240899 · ClinicalTrials.gov registry record · NA

Yoga for Anxiety in Adults

A NA study of Anxiety and Parkinson Disease, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04240899: Completed NA study of Anxiety and Parkinson Disease, sponsored by Rutgers, The State University of New Jersey.

NCT04240899 is a NA study of Anxiety and Parkinson Disease that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 16 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04240899, a NA study of Anxiety and Parkinson Disease, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the effect of a telerehabilitation-yoga intervention delivered remotely via videoconferencing on adults with Parkinson's Disease and anxiety symptoms.

Primary Outcome

The 12-item self-report PAS will be used to assess anxiety symptoms. It takes approximately 2-minutes to complete and is a 12-item scale with three sub-scales assessing 1. Persistent anxiety, episodic anxiety, and avoidance behavior. Participants answer questions on a scale from "not or never" (0) to "severe or almost always" (4) with a potential score range of 0-48. Higher score indicates greater symptoms of anxiety.

Interventions

  • OTHER Tele-yoga

Study Locations (1)

New Jersey

  • Rutgers University - Newark

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2020-03-09
Est. Completion 2021-07-14
Phase NA

What the finished NCT04240899 record still lists

NCT04240899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Tele-yoga is the first listed.

NCT04240899 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT04240899 about?

NCT04240899 is a clinical study titled "Yoga for Anxiety in Adults". The purpose of this study is to investigate the effect of a telerehabilitation-yoga intervention delivered remotely via videoconferencing on adults with Parkinson's Disease and anxiety symptoms.

What is the current status of trial NCT04240899?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2020-03-09. Estimated completion is 2021-07-14.

What conditions does trial NCT04240899 study?

This clinical trial studies the following conditions: Anxiety, Parkinson Disease.

What interventions are being tested in trial NCT04240899?

The interventions under investigation include: Tele-yoga (OTHER).

Who is sponsoring clinical trial NCT04240899?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04240899 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04240899's enrollment target sits among peer trials

16 342nd of 364 higher than 21 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04240899, the US trial registry maintained by the National Library of Medicine. NCT04240899 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.